Bisulfite-free, base-resolution identification of cytosine modifications
EP3720560A1
Methods of treating cancer with plk4 inhibitors
US2020338125A1
Method for expansion of lymphocytes
AU2018328324A1
Selective labeling of 5-methylcytosine in circulating cell-free DNA
WO2018144410A1
Enhanced immune cell receptor sequencing methods
CN109641933A
The full-length genome identification of chromatin interaction
CA3029332A1
Methods and compositions for pdgf-cc inhibition
WO2017218737A2
Methods of small-rna transcriptome sequencing and applications thereof
EP3356559A1
Typing and assembling discontinuous genomic elements
EP3353154A1
3-hydroxy-7-(sulfonyl)quinazoline-2,4(1h,3h)-dione and 3-hydroxy-pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives and related compounds as flap-endonuclease 1 (fen-1) inhibitors for use in cancer therapy
US2018148501A1
TGF-β3 specific antibodies and methods and uses thereof
EP3283482A1
Plk4 inhibitors
AU2015213481A1
Anti-Metalloprotease antibody for diagnosis and treatment of cancers
